Status:
COMPLETED
Repetitive Transcranial Magnetic Stimulation Versus Botulinum Injection on Spasticity on Children With Diplegic Cerebral Palsy
Lead Sponsor:
MTI University
Conditions:
Spastic Diplegic Cerebral Palsy
Eligibility:
All Genders
4-4 years
Phase:
NA
Brief Summary
This trial will enroll 75 children with spastic diplegic cerebral palsy both matched in age, sex, degree of disability and cognitive functions with the same exclusion criteria undergoing the same phys...
Detailed Description
This trial will enrol 75 children with spastic diaplegic cerebral palsy with both sex, degree of disability and cognitive functions with the same exclusion criteria and the same physical therapy progr...
Eligibility Criteria
Inclusion
- were diagnosed based on history taking including perinatal, developmental, and family history, general and neurological examination.
- The included children with clinical diagnosis of moderate spastic dialogic cerebral palsy with a MAS (1, 1+, 2) and GMFCS (II, III, IV) were participated in this study
Exclusion
- Children who's contraindicated to rTMS treatment have metal implants such as internal pacemakers and intracranial scaffolds, and/or a history of epilepsy.
- Children who's Contraindicated for BTX-A treatment: hypersensitivity and local infection at the injection site.
- Children which have received a local injection of BTX-A within 3 months.
- Children with dyskinetic CP,
- Mental retardation,
- previous, seizure or contracture were excluded.
Key Trial Info
Start Date :
October 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 10 2024
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06218316
Start Date
October 15 2023
End Date
August 10 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of pysical therapy, MTI university
Cairo, Egypt